Tada Hiroomi 4
4 · Tyra Biosciences, Inc. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Common Stock
2024-03-15$6.58/sh+1,968$12,947→ 86,435 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.